| Net Cash Provided by (Used in) Operating Activities |
-271K |
USD |
-3384% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
1.93M |
USD |
+24795% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
-1.51M |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
500M |
shares |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
409M |
shares |
+61.2% |
Q4 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
148K |
USD |
|
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
148K |
USD |
|
Q3 2025 |
Q1 2026 |
| Cash and Cash Equivalents, Period Increase (Decrease) |
-30 |
USD |
|
Q3 2024 |
Q1 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
20M |
shares |
|
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
1.57M |
USD |
|
Q3 2025 |
Q1 2026 |
| Interest Expense |
-642K |
USD |
|
Q3 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q1 2026 |